Edenfield William J - Institute for Translational Oncology Research

基本信息

浏览量：61

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 58 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Multi-Center, Open-Label Phase 1/1b Dose Finding, Safety, and Pharmacokinetic Study of MBRC-101, an Anth-EphA5 Monomethyl Auristatin (MMAE) Antibody Drug Conjugate, in Advanced Refractory Solid Tumors

Shiraj Sen,Mohamad Adham Salkeni, Costantine Albany, Neel Jitendra Gandhi,William Jeffery Edenfield,Kellogg Parsons,Isan Chen,John D. Powderly

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Intravenous Infusion (IV) or Intracavitary Perfusion (IP) of T3011, an Oncolytic HSV Expressing IL-12 and PD-1 Antibody: Analyses of Two Phase 1 Studies

Jiaxin Niu,Minal A. Barve,Alexander I. Spira,William Jeffery Edenfield, Kevin Wang, Gaiyun Liu,Meredith McKean,Wenmin Fu,Meng Qiu, Peng Cheng

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Phase 1 Study of BDTX-1535, an Oral 4th Generation Covalent EGFR Inhibitor, in Patients with Recurrent Glioblastoma: Preliminary Dose Escalation Results

Patrick Y. Wen,Melissa Lynne Johnson,Jason Timothy Henry,Alex Spira,James Battiste,Iyad Alnahhas,Do-Hyun Nam,Jyoti D. Patel,William Jeffery Edenfield,Adilia Hormigo, Shinkyo Yoon,Tae Min Kim,Sudharshan Eathiraj,Julio Hajdenberg,Sergey Yurasov,Manmeet Singh Ahluwalia

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

NGM707 in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumors: Preliminary Results from Dose Escalation

Judy S. Wang,Manish R. Sharma,William J. Edenfield,Kartik Sehgal, Do-Youn Oh, Yixing Jiang, Joel Michalski,Jeeyun Lee,Hans Hammers,Li-Yuan Bai, Chih-Hung Hsu, Brenda Dampier, Kefei Zhou,Li Yan, Lisa K. Blum, Joanne Sloan-Lancaster,Daniel D. Kaplan, Dhiraj Abhyankar, Hsiao D. Lieu, Vladimir Hanes,Aung Naing

CANCER RESEARCHno. 7 (2024)

引用0浏览0引用

Phase 1 Study of CTX-471, a Novel CD137 Agonist Antibody, in Patients with Progressive Disease Following PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

Minal A. Barve,Tanner Michael Johanns,Niharika B. Mettu,Seth D. Rosen,William Jeffery Edenfield,Martin Gutierrez, Aime Giorlando,Thomas Schuetz

Journal of Clinical Oncologyno. 16_suppl (2024): 2535-2535

引用0浏览0引用

MT-6402, an Engineered Toxin Body (ETB) Targeting PD-L1: Interim Efficacy and Safety Data

Minal A. Barve,Brian Andrew Van Tine,Rebecca A. Redman,Steven Francis Powell,William Jeffery Edenfield,Julio Antonio Peguero,Victoria Meucci Villaflor,Karen Stein,Chris Moore,Rachael Orlandella,Swati Khanna,Joseph Dekker, Silvia Ferrati, Soratree Charoenthongtrakul,Yanning Liu,Kristina Dabovic, David R. Spigel

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Development and Validation of an Integrative Pan-Solid Tumor Predictor of PD-1/PD-L1 Blockade Benefit

Communications medicineno. 1 (2023): 14-14

引用9浏览0WOSNATURE引用

Intravenous (IV) Infusion of T3011, an Oncolytic HSV Expressing IL-12 and PD-1 Antibody, As Monotherapy in Advanced Solid Tumors: Preliminary Results from an Ongoing Phase 1/2a Study

Jiaxin Niu,Minal A. Barve,Alexander I. Spira,William Jeffery Edenfield,Weijia Pang,Wenmin Fu, Yingxin Lu,Meredith McKean

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Assessment of Prognostic Ability of Galectin-1, -3, and -9 in Lung Cancer Patients

Hayden Shuster,Avery Funkhouser, Lorie Allen,Julie Martin,William Jeffery Edenfield,Anna Blenda

crossref（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn